Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Simon

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Geriatrics|June 23, 1999
Arthritis: new agents herald more effective symptom managementL S Simon
Current Opinion in Rheumatology|May 10, 2000
Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?L S Simon
International Journal of Clinical Practice|July 27, 2000
DMARDs in the treatment of rheumatoid arthritis: current agents and future developmentsL S Simon
Gastroenterology Clinics of North America|January 5, 2002
COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?L S Simon
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: An abbreviated regulatory guide to the clinical requirements for development of therapeutics in osteoarthritisL S Simon
The Journal of Rheumatology|July 16, 1999
Risk factors and current NSAID useL S Simon
The Journal of Rheumatology. Supplement|February 11, 1999
The American College of Rheumatology Core Curriculum--a problem based learning curriculum: rationale and designL S Simon
Current Opinion in Rheumatology|June 1, 1991
Toxicity of the nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|June 1, 1989
Toxicity of nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|May 1, 1997
Biologic effects of nonsteroidal anti-inflammatory drugsL S Simon
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Geriatrics|June 23, 1999
Arthritis: new agents herald more effective symptom managementL S Simon
Current Opinion in Rheumatology|May 10, 2000
Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?L S Simon
International Journal of Clinical Practice|July 27, 2000
DMARDs in the treatment of rheumatoid arthritis: current agents and future developmentsL S Simon
Gastroenterology Clinics of North America|January 5, 2002
COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?L S Simon
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: An abbreviated regulatory guide to the clinical requirements for development of therapeutics in osteoarthritisL S Simon
The Journal of Rheumatology|July 16, 1999
Risk factors and current NSAID useL S Simon
The Journal of Rheumatology. Supplement|February 11, 1999
The American College of Rheumatology Core Curriculum--a problem based learning curriculum: rationale and designL S Simon
Current Opinion in Rheumatology|June 1, 1991
Toxicity of the nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|June 1, 1989
Toxicity of nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|May 1, 1997
Biologic effects of nonsteroidal anti-inflammatory drugsL S Simon
Pageof 8